FDA asks judge to delay full release of Pfizer’s COVID shot data to the public until 2076

FDA asks judge to delay full release of Pfizer’s COVID shot data to the public until 2076

The U.S. Food and Drug Administration wants to delay the release of Pfizer’s full COVID-19 mRNA jab data until the year 2076, a far-flung target date some 55 years after the federal agency gave the green light to roll out the experimental shots to millions of people in the country, according to a court document released in response to a legal challenge demanding transparency.

The FDA’s request to drag out the release of the information has raised questions about the legitimacy and safety of the COVID-19 drugs, which many are essentially forced to take in order to keep their livelihoods or participate in society thanks to top-down government mandates, city ordinances, and requirements by private employers.

“The FDA has asked a federal judge to make the public wait until the year 2076 to disclose all of the data and information it relied upon to license Pfizer’s COVID-19 vaccine,” wrote attorney Aaron Siri in a November 17 Substack post.

“That is not a typo,” Siri said. “[The FDA] wants 55 years to produce this information to the public.”

The request by the FDA came as Siri’s law firm, Siri Glimstad, has spent months trying to obtain the documents on behalf of over 30 concerned scientists, professors, and other academics.

In August, just after the FDA granted full approval of the Pfizer shot for people aged 16 and up, a group of prominent academics and scientists with Public Health and Medical Professionals for Transparency, represented by Siri Glimstad, unsuccessfully submitted a Freedom of Information Act Request (FOIA) to the FDA, demanding it release the information it used to approve Pfizer’s double-shot injection.

The nonprofit organization named as the plaintiff in the lawsuit boasts such eminent public health professionals as Yale professor of epidemiology Dr. Harvey Risch, Dr. Aaron Kheriaty, Dr. Peter McCullough, Florida Surgeon General Dr. Joseph Ladapo, former WHO and HHS advisor Dr. Paul E. Alexander, and Dr. Byram W. Bridle, among others.

In September, after the FDA failed to release the data on an expedited basis as requested, the group filed a lawsuit against the federal agency in the U.S. District Court for the Northern District of Texas.

The plaintiffs have demanded the FDA release the full data no later than March 3, 2022.

Now, according to the court filing, the FDA is requesting to draw out the release of the important data over the span of more than five decades, citing a “significant risk of inadvertent disclosure of records properly subject to exemption under FOIA” if they were to release the documents more quickly.

“[T]wo days ago, the FDA asked a federal judge to give it until 2076 to fully produce this information,” Siri explained. “The FDA asked the judge to let it produce the 329,000+ pages of documents Pfizer provided to the FDA to license its vaccine at the rate of 500 pages per month, which means its production would not be completed earlier than 2076.”

“That makes me want to see the data right now,” commented Dr. David Samadi in response to the news, noting that the FDA is asking “for a full 55 years” before releasing the information it “relied on to deem Pfizer’s vaccine safe for usage” for millions of people around the world.

“Why would the American people accept this?” asked California state congressional candidate Amy Phan West, arguing that “[w]e need some fighters in Congress who will demand answers NOW!”

The plaintiffs in the legal challenge argue that transparency from the FDA is especially vital given that Americans are being coerced into taking the shots. Further, they point out that Pfizer, a massive global pharmaceutical company with a market cap of $288.7 billion, has been granted total immunity from any financial liability should any of the millions of people who have chosen to or been coerced into getting the jab suffer injury from it.

“It is difficult to imagine a greater need for transparency than immediate disclosure of the documents relied upon by the FDA to license a product that is now being mandated to over 100 million Americans under penalty of losing their careers, their income, their military service status, and far worse,” the court filing reads.

“The acute need for transparency regarding this product is heightened by the fact that the secretary of Health and Human Services (“HHS”), the FDA’s parent department, has granted Pfizer complete immunity from financial liability for any injury caused by its product,” the filing states.

“If injured — including suffering one of the injuries even federal health authorities admit occur from Pfizer’s product — the injured individual effectively has no recourse,” the plaintiffs continued, adding that “[t]he fact that [the FDA] has fought tooth and nail and taken such an absurd and unconscionable position of waiting until the year 2076 to complete the production further heightens the grave need to have these documents produced forthwith.”

The legal wrangling over a full release of Pfizer’s COVID-19 drug information comes after the FDA has made repeated promises to provide “full transparency” to the public with respect to the authorization of COVID-19 shots.

Siri pointed out that the FDA had reaffirmed its “commitment to transparency” during the licensing of the Pfizer injections, and accused the federal agency of violating its commitment by refusing to make public the records it used to authorize the shots.

“The federal government shields Pfizer from liability,” he said. “Gives it billions of dollars. Makes Americans take its product. But won’t let you see the data supporting its product’s safety and efficacy.”

“The FDA’s promise of transparency is, to put it mildly, a pile of illusions,” Siri said. “Who does the government work for?”